Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Financials pace gains as Footsie keeps climbing

Mon, 20th Jun 2016 12:29

(ShareCast News) - Stocks in London were continuing to move higher come midday on Monday, alongside the largest gain the pound in three months, with investors taking their cue from strong gains in Asia as Brexit polls showed the Remain campaign was in the lead.As of 12:03 BST, the FTSE 100 was 183.60 points or 3.05% higher at 6,204.69, led higher by gains in financials such as Hargreaves Lansdown and RBS together with housebuilders, including Taylor Wimpey and Barratt Developments.Against the US dollar, the pound was gaining 1.84% to 1.4629. In parallel, front month Brent crude futures gained 1.64% to $49.99 per barrel on the ICE. Three-month LME-traded copper futures on the other hand were down by 1.2% to $4,552 per metric tonne.Over the weekend, a Survation poll in the Daily Mail revealed that support for the 'Remain' campaign was in the lead at 45.0% versus 42.0% for 'Leave', while two YouGov polls - one for ITV's Good Morning Britain and one for the Sunday Times - both showed Remain in front.In addition, a ComRes poll for the Sunday Mirror revealed the percentage of people saying they'd be relieved if the UK stayed in the EU rose to 45% after the murder of MP Jox Cox, from 35% before.Meanwhile, an opinion survey conducted for the Observer between Tuesday and Friday showed an even split but of the 10% undecided, 36% said they were leaning towards Remain.According to Oddschecker's tally of the odds being offered by bookmakers, the chances of 'Remain' coming out on top were being put at 31%, down from a record 44.0% just before the killing of lawmaker Jo Cox."We're still getting some rather ludicrous predictions of what the pound might do in the event of a "leave" vote, which to some extent has caused some rather extreme positioning, and will likely contribute to a lot more choppiness in the coming days, as this morning's Asia surge catches an awful lot of people the wrong way round," said Michael Hewson, chief market analyst at CMC Markets UK.BT Group, TalkTalk jump"With growing mobile data usage, we see mobile as an essential utility," UBS analyst Polo Tang said in a research note sent to clients. In case of 'Bremain', Tang expected a rebound in the likes of Sky, BT and TalkTalk. Those UK-centric three names had already underperformed going into the EU referendum (although they were relatively resilient operationally in the last downturn), he said.Heavily indebted North Sea oil producer EnQuest has denied media reports that it is in talks with the UK Oil and Gas Authority (OAG) about contingency plans. The government body fears insolvencies at Enquest and mid-cap peer Premier Oil, the Sunday Telegraph reported, and is mulling plans "to guard against a North Sea bankruptcy crisis" as the pair are "wracked with debt following the oil market rout and now stand at the mercy of their lenders".Gemfields, a British supplier of responsibly sourced coloured gemstones, reported record total revenues of $44.3m at a recent auction of rough rubies in Singapore as the increasing quality of Mozambique gems attracts growing demand.Shares in biopharmaceutical development company Circassia Pharmaceuticals plummeted on Monday morning, after it announced disappointing top-line results from its investigational cat allergy immunotherapy phase III study.Hammerson said it has exchanged contracts and completed the sale of Thurrock Shopping Park, Essex, to TH Real Estate for £93m. The sale price represents a net initial yield of 5.3% and is moderately below the book value as at 31 December 2015, Hammerson said.Late-stage drug trials by GlaxoSmithKline on its treatment for chronic obstructive pulmonary disease (COPD) have proved successful. The Phase III clinical testing by GSK and project partner Innoviva delivered data that is likely to support European regulatory submission by the end of 2016.FTSE 250 precision instruments maker Spectris has completed the acquisition of the software and associated assets of privately-held software solutions company Capstone Technology Corp for $22.5m. Capstone comprises two key software platforms: the MACS software suite providing engineering services and software for advanced process control optimisation and dataPARC, which is a data historian, visualisation and analytics software suite for operational decision support.Market MoversFTSE 100 (UKX) 6,216.27 3.24%FTSE 250 (MCX) 16,904.12 2.94%techMARK (TASX) 3,060.79 3.20%FTSE 100 - RisersHargreaves Lansdown (HL.) 1,320.00p 7.40%Royal Bank of Scotland Group (RBS) 238.40p 7.34%Taylor Wimpey (TW.) 187.80p 6.70%Worldpay Group (WI) (WPG) 291.70p 6.50%Barratt Developments (BDEV) 566.00p 6.49%Lloyds Banking Group (LLOY) 69.26p 6.47%St James's Place (STJ) 875.50p 6.25%Barclays (BARC) 175.95p 6.15%Aviva (AV.) 431.40p 6.02%International Consolidated Airlines Group SA (CDI) (IAG) 505.50p 5.69%FTSE 100 - FallersRandgold Resources Ltd. (RRS) 6,445.00p -2.50%Fresnillo (FRES) 1,213.00p -1.14%Rexam (REX) 627.50p -0.32%SABMiller (SAB) 4,288.00p 0.76%Rio Tinto (RIO) 2,028.00p 1.12%Antofagasta (ANTO) 431.30p 1.75%Hikma Pharmaceuticals (HIK) 2,189.00p 2.00%HSBC Holdings (HSBA) 440.25p 2.10%National Grid (NG.) 979.00p 2.11%BHP Billiton (BLT) 848.40p 2.12%FTSE 250 - RisersEvraz (EVR) 118.60p 8.71%Paragon Group Of Companies (PAG) 294.30p 6.82%Greggs (GRG) 1,089.00p 6.66%St. Modwen Properties (SMP) 318.40p 6.38%AA (AA.) 279.80p 6.27%Bovis Homes Group (BVS) 986.50p 6.25%Bellway (BWY) 2,711.00p 6.23%Serco Group (SRP) 109.60p 6.10%Unite Group (UTG) 640.50p 6.04%Virgin Money Holdings (UK) (VM.) 342.70p 6.03%FTSE 250 - FallersCircassia Pharmaceuticals (CIR) 96.75p -64.21%Centamin (DI) (CEY) 109.10p -1.89%Acacia Mining (ACA) 330.90p -1.63%Allied Minds (ALM) 330.00p -1.29%Templeton Emerging Markets Inv Trust (TEM) 459.40p -0.73%P2P Global Investments (P2P) 844.00p -0.65%BH Macro Ltd. GBP Shares (BHMG) 1,939.00p -0.41%Riverstone Energy Limited (RSE) 866.50p -0.40%Vectura Group (VEC) 156.60p -0.25%IP Group (IPO) 167.20p -0.18%
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.